Stock_Titan
Posted - 10 hours ago
$ALKS Alkermes to Report First Quarter Financial Results on May 1, 2024
https://www.stocktitan.net/news/ALKS/alkermes-to-report-first-quarter-financial-results-on-may-1-3sgs7b91zejg.html
Shanghi18
Posted - 12 hours ago
$ALKS out 24.46 w 1.5% . Crappy mkt day. I'll take it
Shanghi18
Posted - 14 hours ago
$ALKS in 24.08 with a wicked tight stop. Didn't even chk RSI but this is beat down
PrivateEquity101
Posted - 1 day ago
$ALKS 💸💸💸💸 keep on bringing it down!!
PrivateEquity101
Posted - 5 days ago
$ALKS the fact people are bullish on this tells me there are true morons out there who trade stocks 😂😂😂 you will make money in this being short all the way down to $15....
Broncos07
Posted - 5 days ago
$ALKS liking the looks of lvl 2 … maybe a halt on the way up? 😉 we can hope!
PrivateEquity101
Posted - 5 days ago
@Broncos07 was referring to $ALKS
Broncos07
Posted - 6 days ago
$MNDR on the dip situation- $ALKS just tanked…. Might b 1 to watch when it calms down…. IMO… not advice. Do you DD
TeresaTrades
Posted - 6 days ago
Largest PUT OI decreases $ALKS $TSLA $CMCSA $NVAX $AGNC
WaynD01
Posted - 1 week ago
$ZVRA Yesterday, $200M was added to the $ALKS MC by a 9/8 patients Narco/IH phase 1b study result. How much value addition we got from a 48 person phase 2 result?
https://investor.alkermes.com/news-releases/news-release-details/alkermes-announces-positive-topline-results-phase-1b-study-alks
AnaChart
Posted - 1 week ago
$ALKS
https://anachart.com/wp-content/uploads/ana_temp/1712689349_soc-img.jpg
OpinicusTrades
Posted - 1 week ago
4 stocks to watch today: $TLRY $GE $TSM $ALKS
tradingtwenty
Posted - 1 week ago
$ALKS has trended 2 times in the past 24 hours (based on 5 minute intervals). Latest press release on Apr 09, 2024 07:00 AM: Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness... Link: https://tradingtwenty.com/news/423030/alkermes-announces-positive-topline-results-from-phase-1b-study-of-alks-2680-demonstrating-improved-wakefulness-in-patients-with-narcolepsy-type-2-and-idiopathic-hypersomnia
OpenOutcrier
Posted - 1 week ago
$ALKS (+6.9% pre) Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia - PRN https://ooc.bz/l/29845
DonCorleone77
Posted - 1 week ago
$ALKS Alkermes' ALKS 2680 improves wakefulness in Phase 1b narcolepsy study Alkermes announced positive topline results from the narcolepsy type 2 - NT2 - and idiopathic hypersomnia - IH - cohorts of a phase 1b, proof-of-concept study evaluating ALKS 2680, the company's novel, investigational, oral orexin 2 receptor agonist in development as a once-daily treatment for narcolepsy. ALKS 2680 data demonstrated clinically meaningful and statistically significant improvements from baseline in mean sleep latency on the Maintenance of Wakefulness Test vs. placebo at all doses tested. ALKS 2680 was generally well tolerated in both patient populations at all doses tested. The company plans to initiate a phase 2 study in patients with NT2 in the second half of 2024. Alkermes expects to submit results from this phase 1b, proof-of-concept study to a peer-reviewed journal for publication and to present additional ALKS 2680 study results at upcoming scientific meetings.
Stock_Titan
Posted - 1 week ago
$ALKS Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
https://www.stocktitan.net/news/ALKS/alkermes-announces-positive-topline-results-from-phase-1b-study-of-vx911duv6ckp.html
PrivateEquity101
Posted - 1 week ago
$ALKS I'll buy this when it goes under $20 -- Until then, short the heck out of this. CEO is a clown, DEI initiatives up the wazoooo... some would wonder if they even care about the science anymore...
Stock_Titan
Posted - 1 week ago
$ALKS Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
https://www.stocktitan.net/news/ALKS/alkermes-presents-analyses-from-long-term-safety-study-of-lybalvi-r-7ba4qyhouamr.html
PrivateEquity101
Posted - 2 weeks ago
$ALKS any one not shorting this is a clownn, just like their CEO. Layoffs every week. Positions overrun by DEI hires. CEO is running company into the ground.
StockInvest_us
Posted - 2 weeks ago
Signal alert: $ALKS - PivotPoint bottom https://stockinvest.us/l/FQf9MfCf3I
Fullratio
Posted - 03/27/24
Healthcare sector stocks with high YoY EPS growth in Q4 2023: $ROIV $ZBH $ALKS
StockInvest_us
Posted - 03/22/24
Signal alert: $ALKS - PivotPoint bottom https://stockinvest.us/l/Rtf2vZAojG
PrivateEquity101
Posted - 03/20/24
$ALKS short this into the ground. bad product. even worse leadership.
richardred
Posted - 03/19/24
$ALKS IMO one of the biggest values in Bio. Who knows maybe partner J&J might want the whole thing?
Quantumup
Posted - 03/19/24
Baird🏁 $ALKS OP/$37 Notes rev guide $1.5B-$1.6B/>$800M in cash=solid fl; believes ALKS 2680 has💪🏽pot for narcolepsy type 1 (allots $7 per shr & *leaves narcolepsy type 2/idiopathic hypersomnia as*upside), as drug works on the causal pathway of disease, w/ compelling P1b data2date.
stoxx0007
Posted - 03/19/24
$ALKS = but more insiders selling is not looking good here. 😕
stoxx0007
Posted - 4 weeks ago
$ALKS = since there's a huge short position here.... I'd like to see a massive short squeeze to take ALKS above $60
StockInvest_us
Posted - 1 month ago
Signal alert: $ALKS - Oversold Trend Short (Undervalued) https://stockinvest.us/l/pTM5IRwtND
Walls10
Posted - 1 month ago
@Thiel44 @Hawaiianinvesta he definitely knew what he was/is doing with $ALKS and $IRWD
BitJennie700k
Posted - 1 month ago
$ALKS starter